The SARS-CoV-2 501Y.V2 lineage has been recently been shown to predominate in the Eastern Cape, Western Cape and KwaZulu-Natal provinces of South Africa, all of which experienced major outbreaks of COVID-19.  This...

By NewsDesk  @bactiman63 The Alaska Department of Health and Social Services (DHSS)  announced last week that an Anchorage resident who tested positive for SARS-CoV-2 infection last month was infected...

AstraZeneca’s COVID-19 vaccine has been granted a conditional marketing authorisation (CMA) in the European Union (EU) for active immunisation to prevent COVID-19 caused by SARS-CoV-2, in individuals...

By NewsDesk  @bactiman63 The new Brazilian variant of COVID-19 is already present in 91 percent of COVID-19 cases analyzed in the state of Amazonas, which is experiencing a dramatic health collapse,...

By NewsDesk  @infectiousdiseasenews Following the report out of South Carolina two days ago concerning the first two cases in the US associated with the SARS-CoV-2 variant that first emerged recently...

By NewsDesk  @bactiman63 The Illinois Department of Public Health (IDPH) is reporting one laboratory-confirmed case of the mumps affecting one off-campus Western Illinois University student in Macomb. Health...

By NewsDesk  @bactiman63 The Food and Drug Administration (FDA) Thursday issued an Emergency Use Authorization (EUA) to AstraZeneca’s COVID-19 vaccine, three weeks after its application. “It...

By NewsDesk  @bactiman63 The Centers for Disease Control and Prevention (CDC) reported one human infection with a novel influenza A virus in Wisconsin. This person was infected with an influenza A(H3N2)...

In a follow-up on the “superbug” NDM-1 outbreak reported in Tuscany, the Regional Health Agency (ARS Toscana) reports the outbreak of New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant...

By

The Carter Center announced this week that the number of Guinea worm disease cases dropped by 50% in 2020 compared to 2019. This includes a dramatic decrease in cases in the country of Chad. What’s more,...